‘Promising’ treatment could ‘modestly slow the pace of cognitive decline’
In a critical boost to President Joe Biden’s reelection prospects, the Food and Drug Administration has approved a new Alzheimer’s drug that “may modestly slow the pace of cognitive decline,” according to the New York Times.
Read the full story here: https://freebeacon.com/biden-administration/joe-biden-alzheimers/
